On July 10, 2024, the company announced that two of its main investors: Michał Lach and Robert Dziubłowski significantly increased their involvement in NanoGroup S.A. Robert Dziubłowski doubled the number of shares and stakes held in the company, and Michał Lach increased his involvement more than two and a half times. They now have a total of more than 20% in their hands! The funds obtained by the company as part of the completed increase in the share capital of NanoGroup S.A. will be used to develop its main areas of activity, i.e. a comprehensive, proprietary system (device and fluid) for extracorporeal storage and regeneration of organs for transplantation NanOX, developed by NanoSanguis S.A., and a proprietary nanoparticle platform, including polysaccharide nanoparticles, in NanoVelos S.A. – We are pleased to have the support of such serious investors. Their trust is extremely important to us and – in my opinion – shows that as a company we are a reliable business partner – says Przemysław Mazurek, President of the Management Board of NanoGroup S.A.